Ed Rayner

Develops, manufactures and wholesales pharmaceutical products for respiratory disorders

Dexus is an active manager which invests in equity, fixed-income, real estate, infrastructure, and multi-asset and diversified securities. Their investment approach is driven by research, access to their global network and progressive portfolio construction following proprietary processes. Portfolio managers focus on specific markets while maintaining flexibility to invest opportunistically. The firm's investment process is a combination of top-down and bottom-up approaches. In addition to equity portfolios, Dexus manages yield-oriented strategies invested in government and non-government debt, emerging market debt, hybrid securities, derivatives, infrastructure debt, listed and direct real estate. They also manage hedge funds, including an Australian market neutral strategy which follows an enhanced index investment approach. They are also a major wholesale real estate manager and design real estate-backed investment products.

ABAL is a research-driven, value-oriented manager which follows both a top-down and bottom-up investment process. The firm's investment services consist of equities, fixed-income, multi-asset and alternatives. The investment management team collectively determines preferred portfolio positions and constructs portfolios with securities that are fundamentally attractive and undervalued based on bottom-up credit research. Portfolio construction aims to consistently maintain portfolio risk positions by incorporating the best ideas generated from their research process. ABAL also uses in-house developed systems to implement and manage multiple risk positions across portfolios.

Functions as a College/University

Operates as a global venture capital firm

Operates as a biotechnology company which develops a technology for genetic and epigenetic analysis